Results 261 to 270 of about 655,937 (417)

The Donation Registry [PDF]

open access: yes, 2003
To redistribute income, charitable giving must supplement progressive taxes. One person can sometimes observe another’s donations to specific charities, but one person cannot observe another’s total donations to all charities. Consequently, people do not have enough information to know whether each person is doing his fair share of charitable giving ...
openaire   +2 more sources

Identification of functional and diverse circulating cancer‐associated fibroblasts in metastatic castration‐naïve prostate cancer patients

open access: yesMolecular Oncology, EarlyView.
Cancer‐associated fibroblasts (CAFs) promote cancer growth, invasion (metastasis), and drug resistance. Here, we identified functional and diverse circulating CAFs (cCAFs) in patients with metastatic prostate cancer (mPCa). cCAFs were found in higher numbers and were functional and diverse in mPCa patients versus healthy individuals, suggesting their ...
Richell Booijink   +6 more
wiley   +1 more source

Exploring grief and acceptance: Experiences and needs of family members of deceased organ donors. [PDF]

open access: yesSAGE Open Med
Latifi M   +5 more
europepmc   +1 more source

Pigment Donation In Vitro

open access: bronze, 1964
C. N. D. Cruickshank, Susan A. Harcourt
openalex   +1 more source

Surfaceome: a new era in the discovery of immune evasion mechanisms of circulating tumor cells

open access: yesMolecular Oncology, EarlyView.
In the era of immunotherapies, many patients either do not respond or eventually develop resistance. We propose to pave the way for proteomic analysis of surface‐expressed proteins called surfaceome, of circulating tumor cells. This approach seeks to identify immune evasion mechanisms and discover potential therapeutic targets. Circulating tumor cells (
Doryan Masmoudi   +3 more
wiley   +1 more source

The acceptances and associated influences of body donation in Mainland China: a national cross-sectional study. [PDF]

open access: yesSci Rep
Wu J   +10 more
europepmc   +1 more source

Clinical applications of next‐generation sequencing‐based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progression

open access: yesMolecular Oncology, EarlyView.
Circulating tumor DNA (ctDNA) offers a possibility for different applications in early and late stage breast cancer management. In early breast cancer tumor informed approaches are increasingly used for detecting molecular residual disease (MRD) and early recurrence. In advanced stage, ctDNA provides a possibility for monitoring disease progression and
Eva Valentina Klocker   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy